medline.ch Urologie-Nephrologie

	Endothelial activation and stress index in risk stratification and treatment optimization for critically ill patients with acute kidney injury: A retrospective cohort study from MIMIC-â…£ database. PLoS One Liang C, Wang K. PMID: 42090376 [PubMed - indexed for MEDLINE]
	Aldosterone Synthase Inhibition in Kidney Transplantation: Class Rationale, Translational Promise, and the Limits of Current Evidence. Clin Transplant Corrêa LMA, Brandão LKV, Santiago CBG, Barbosa AA, Mazur GR, de de Santana GC, Silva YRD, Dante LE, Dutra Júnior IF. PMID: 42090239 [PubMed - indexed for MEDLINE]
	Anaerobe-Driven Inflammation and Epithelial Barrier Disruption in Genital HIV Acquisition. Am J Reprod Immunol Constable S, Minazadeh Y, Buchanan LB, Ssemunywa H, Galiwango RM, Kaul R, Prodger JL. PMID: 42090226 [PubMed - indexed for MEDLINE]
	Long-term safety of overactive bladder medications in men receiving pharmacotherapy for benign prostatic enlargement: a real-world study using inverse probability of treatment weighting. Int Urol Nephrol Soda T, Yamauchi T, Otsuka H, Makino Y, Okada T. PMID: 42090096 [PubMed - as supplied by publisher]
	Face and content validation of laser enucleation of prostate simulation model: an EAU European School of Urology (ESU) Lower Urinary Tract Endoscopy Working Group study. World J Urol Sener TE, de Oliveira TR, Demirkiran ED, Perri D, Pereira S, Caballero JP, Osorio L, Kartalas IG, Goossens M, Schoensee B, Dragos L, Veneziano D, Biyani CS, Somani B, Liatsikos E. PMID: 42090017 [PubMed - indexed for MEDLINE]
	Therapeutic applications of phosphodiesterase inhibitors in male reproductive health: narrative review. Sex Med Rev Ninjoor YK, Madhvacharya VV, Kumari S, Nagaraja MR, P C J, Hanuman DS, Rajakumara E, Kodithuwakku SP, Adiga SK, Acharya KK, Kalthur G. PMID: 42089748 [PubMed - indexed for MEDLINE]
	Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis. Acta Oncol Caeyman A, Mammone G, Kinget L, Baldewijns M, De Wever L, Albersen M, Debruyne PR, Demeulenaere O, McTaggart ES, Saraswat S, Berghen C, De Meerleer G, Naulaerts S, Garg AD, Beuselinck B. PMID: 42089693 [PubMed - indexed for MEDLINE]
	Â¹â·â·lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer. Expert Rev Anticancer Ther Sciortino C, Nuzzo A, Stellato M, Claps M, Rametta A, Guadalupi V, Gusmaroli E, Rota S, Mascaro F, Giannatempo P, Zimatore M, Maccauro M, Huber V, Verzoni E, Procopio G. PMID: 42089687 [PubMed - as supplied by publisher]
	Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trial. BJU Int Sharifi SHH, Williams A, Ryan JT, Ajami T, Nativ OF, Han S, Reis IM, Soodana-Prakash N, Khandekar A, Swain S, Kryvenko ON, Stoyanova R, Pollack A, Castillo PR, Nahar B, Ritch CR, Kava B, Gonzalgo ML, Parekh DJ, Punnen S. PMID: 42089595 [PubMed - as supplied by publisher]
	Multi-omics insights into tumor grade progression in clear cell renal cell carcinoma: from molecular mechanisms to precision therapeutics. Front Cell Dev Biol Jena RS, Mishra A. PMID: 42089114 [PubMed]
	Machine learning-driven multi-omics integration of urinary organic acids and ions enables precision risk stratification for calcium oxalate nephrolithiasis. Front Med (Lausanne) Zhang P, Liu Y, Su B, Xu Y, Xu Z, Zhang T, Wang Y, Yang J, Liu Y, Li J. PMID: 42089077 [PubMed]
	Guideline-directed medical therapy in Polish patients with chronic coronary syndrome and advanced chronic kidney disease: insights from the ISCHEMIA-CKD trial. Postepy Kardiol Interwencyjnej Praco, Anthopolos R, Lu Y, Demkow M, Mazurek T, Dro, Pruszczyk P, Roik M, Kryczka K, Henzel J, Kaczmarska-Dyrda E, Ma, Teresi, Szwed H, Ru. PMID: 42088959 [PubMed]
	Preoperative Doppler Ultrasound Parameters as Predictors of Arteriovenous Fistula Maturation in End-Stage Renal Disease: A Prospective Cohort Study. Int J Nephrol Renovasc Dis Haji Ahmadi S, Sadeghi Zadeh S, Shahbandari M, Elhaie M. PMID: 42088822 [PubMed]
	Outcomes of pelvic radiotherapy with boost strategies in high nodal-risk prostate cancer: A phase 2 prospective trial. Clin Transl Radiat Oncol Thellenberg Karlsson C, Notstam K, Tavelin B, Lundqvist K, Fransson P, Söderkvist K. PMID: 42088776 [PubMed]
	Predicting Prostate Cancer Risk and Its Associated Factors Using Machine Learning Techniques: A Retrospective Study. Health Sci Rep Mohammadi S, Imani B, Saeedi S, Amirzargar MA. PMID: 42088668 [PubMed]
	Clomiphene citrate and human chorionic gonadotropin treatment before microdissection testicular sperm extraction in non-obstructive azoospermia: a retrospective non-randomized series. Front Reprod Health Al-Zubi M, Ghassab Deameh M, Awawdeh AK, Mohammad RJ, Shannaq AA, Qdisat SM, Mansi RM, Tanashat AY, Mubarak MA, Abu-Khadra B, Bani-Hani M. PMID: 42088652 [PubMed]
	Predicting first-year kidney graft loss at the time of donor offer using machine learning and competing-risk analysis in a Latin American cohort. Clin Kidney J Garcia-Lopez A, Cuervo-Rojas J, Garcia-Lopez J, Giron-Luque F. PMID: 42088642 [PubMed]
	The Brazilian Genome Map Oncology Subproject: a nationwide multicentre hospital-based whole-genome sequencing study of breast, prostate, and colorectal cancer. Lancet Reg Health Am Ferreira FO, Rossi BM, Palmero EI, Carvalho Barros LR, Domingos de Nicola P, Monteiro Dos Santos EM, Pereira de Souza J, Thiago de Souza-Santos P, Matta BP, da Silva Sabato C, Braz NC, Monteleone VF, Campacci N, Bastos GM, Guerra TS, Quirino CV, Pereira N, de Oliveira Costa M, Alves da Silva A, Serra AL, Lopes AJ, Alves Coelho BL, Mylla de Aguiar D, Chagas GL, Silva da Costa J, Lima JF, Jaqueline de Souza M, Oliveira SR, da Fonseca C, Cascapera F, Alencar de Moura FA, Perroni Dos Santos G, Guimaraes da Silva L, Campacci L, Sacilotto L, Soares Dos Santos S, Queiroz WDS, Goto GT, Badesso Fonseca TR, De Oliveira Mattoschoell VY, Rosa RO, Sandoval RL, Gambardella DD, Ciconelli RM, Beraldo da Costa Saad M, Guimaraes GC, Collaborative Working Group . PMID: 42088596 [PubMed]
	Real-world incidence of G3-G4 adverse events in patients with advanced renal cell carcinoma receiving immune-combinations (ARON-1). Front Immunol Beas-Lozano EL, Scagliarini S, Valdez-Sandoval PI, Esparza-Orozco MF, Bilen MA, Bamias A, Li H, Juan Fita MJ, Kopecky J, Manneh Kopp R, Ghosn M, Fay AP, Bhuva D, Kucharz J, Büttner T, Molina-Cerrillo J, Fiala O, Rizzo A, Maiorano BA, Soares A, Buti S, Marques Monteiro FS, Massari F, Santoni M, Bourlon MT. PMID: 42088516 [PubMed - indexed for MEDLINE]
	Advances in immunotherapy for renal cell carcinoma: a comprehensive review. Front Immunol Rajih E, Bakhsh A, Borhan WM, Alqahtani SAM. PMID: 42088496 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 471313

Seite 1 von 23566

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung